Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension (2013)
- Authors:
- USP affiliated authors: GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FORP; FMRP
- DOI: 10.1016/j.redox.2013.11.004
- Subjects: ÓXIDO NÍTRICO; ESTRESSE OXIDATIVO; ENDOTÉLIO VASCULAR; HIPERTENSÃO (EFEITOS DE DROGAS)
- Language: Inglês
- Imprenta:
- Source:
- Título: Redox Biology
- ISSN: 2213-2317
- Volume/Número/Paginação/Ano: v. 1, n. 1, p. 578-585, 2013
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
GUIMARÃES, Danielle A. et al. Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension. Redox Biology, v. 1, n. 1, p. 578-585, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2013.11.004. Acesso em: 26 dez. 2025. -
APA
Guimarães, D. A., Rizzi, E., Ceron, C. S., Pinheiro, L. C., Gerlach, R. F., & Tanus-Santos, J. E. (2013). Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension. Redox Biology, 1( 1), 578-585. doi:10.1016/j.redox.2013.11.004 -
NLM
Guimarães DA, Rizzi E, Ceron CS, Pinheiro LC, Gerlach RF, Tanus-Santos JE. Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension [Internet]. Redox Biology. 2013 ; 1( 1): 578-585.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1016/j.redox.2013.11.004 -
Vancouver
Guimarães DA, Rizzi E, Ceron CS, Pinheiro LC, Gerlach RF, Tanus-Santos JE. Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension [Internet]. Redox Biology. 2013 ; 1( 1): 578-585.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1016/j.redox.2013.11.004 - A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism
- Determinação de gelatinases no fluido gengival em pacientes sadios e com doença periodontal
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells
- Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
Informações sobre o DOI: 10.1016/j.redox.2013.11.004 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
